{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:43Z","timestamp":1740107443905,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00280-018-3571-2","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:23:31Z","timestamp":1522628611000},"page":"965-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["EML4\u2013ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib"],"prefix":"10.1007","volume":"81","author":[{"given":"Thomas","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte J.","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Absher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Kolesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5583-0093","authenticated-orcid":false,"given":"John L.","family":"Villano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"6","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1158\/2159-8290.CD-13-0846","volume":"4","author":"L Friboulet","year":"2014","unstructured":"Friboulet L, Li N, Katayama R, Lee CC, Gainor JF, Crystal AS, Michellys PY, Awad MM, Yanagitani N, Kim S, Pferdekamper AC, Li J, Kasibhatla S, Sun F, Sun X, Hua S, McNamara P, Mahmood S, Lockerman EL, Fujita N, Nishio M, Harris JL, Shaw AT, Engelman JA (2014) The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer. Cancer Discov 4(6):662\u2013673. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0846","journal-title":"Cancer Discov"},{"key":"3571_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.lungcan.2016.10.005","volume":"102","author":"C Gibelin","year":"2016","unstructured":"Gibelin C, Avrillon V, De La Fouchardiere A, Mc Leer-Florin A, Lantuejoul S, Fayette J (2016) Clinical relevance of ROS1 rearrangements detection in advanced squamous cell carcinomas. Lung Cancer 102:42\u201343. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.005","journal-title":"Lung Cancer"},{"issue":"2","key":"3571_CR3","first-page":"2195","volume":"8","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Wang J, Zhang S (2015) ALK-rearranged squamous cell lung cancer: a case report. Int J Clin Exp Pathol 8(2):2195\u20132198","journal-title":"Int J Clin Exp Pathol"},{"issue":"25","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O\u2019Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Janne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385\u20132394. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1214886","journal-title":"N Engl J Med"},{"unstructured":"NCCN Clinical Practice Guidelines. Non small cell lung cancer. V3.2018. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf\n                    \n                  . Accessed 21 Mar 2018","key":"3571_CR5"},{"issue":"5","key":"3571_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/JTO.0000000000000109","volume":"9","author":"A Calio","year":"2014","unstructured":"Calio A, Nottegar A, Gilioli E, Bria E, Pilotto S, Peretti U, Kinspergher S, Simionato F, Pedron S, Knuutila S, Tortora G, Eccher A, Santo A, Tondulli L, Inghirami G, Tabbo F, Martignoni G, Chilosi M, Scarpa A, Brunelli M (2014) ALK\/EML4 fusion gene may be found in pure squamous carcinoma of the lung. J Thor Oncol 9(5):729\u2013732. \n                    https:\/\/doi.org\/10.1097\/jto.0000000000000109","journal-title":"J Thor Oncol"},{"doi-asserted-by":"publisher","unstructured":"Loubiere S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Lena H, Merle P, Mazieres J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J (2018) Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. Eur Resp J 51 (3). \n                    https:\/\/doi.org\/10.1183\/13993003.01467-2017","key":"3571_CR7","DOI":"10.1183\/13993003.01467-2017"},{"issue":"6","key":"3571_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cllc.2017.04.004","volume":"18","author":"ME Gutierrez","year":"2017","unstructured":"Gutierrez ME, Choi K, Lanman RB, Licitra EJ, Skrzypczak SM, Pe Benito R, Wu T, Arunajadai S, Kaur S, Harper H, Pecora AL, Schultz EV, Goldberg SL (2017) Genomic profiling of advanced non-small cell lung cancer in community settings: gaps and opportunities. Clin Lung Cancer 18(6):651\u2013659. \n                    https:\/\/doi.org\/10.1016\/j.cllc.2017.04.004","journal-title":"Clin Lung Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-018-3571-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3571-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3571-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T19:18:24Z","timestamp":1554146304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-018-3571-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1007\/s00280-018-3571-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}